Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib in metastatic renal cell cancer
NCT00569946Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2007
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib in renal cell carcinoma (RCC), sponsored by Pfizer. Started Dec 2007; status: completed.
02
Drugs
axitinib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00569946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00569946.